IMA

IMA

The Icelandic Medicines Agency is the national authority responsible for regulation and surveillance of the development, manufacturing and sale of pharmaceuticals and other medicinal products

85

Employees

At the end of 2021
376.000

Inhabitants in Iceland

At the end of 2021

The IMA is responsible for authorising and licensing medicinal products in the Icelandic market, monitor adverse reactions from medicinal products, authorize clinical trials, decide which medicines are eligible for reimbursement, monitor medical devices available in Iceland and supervise adverse incidents involving medical devices, regulatory surveillance of all pharmacies and pharmacy subsidiaries in Iceland.

2.809

Marketed medicines at the end of 2021

522

Number of MAs issued in 2021

119

Number of New Marketed medicines in 2021